524636 — Oxygenta Pharmaceutical Share Price
Last trade - 00:00- IN₹1.88bn
- IN₹2.99bn
- IN₹1.13bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.22 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -16.59% | ||
| Return on Equity | n/a | ||
| Operating Margin | -3.43% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 605.25 | 309.87 | 396.42 | 1,092.99 | 1,129.82 | n/a | n/a | 16.78% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Oxygenta Pharmaceutical Limited is an India-based company engaged in the manufacturing and selling of pharmaceutical, medical and veterinary preparations. It operates in the pharmaceutical segment. The Company also sells the products to its related companies engaged in the manufacture of formulations. Its active pharmaceutical ingredients (API) products include pantoprazole sodium, vildagliptin, telmisartan, lacosamide, and sertraline hydrochloride. The Company’s chemical products include 3-Amino-1-adamantanol, (S)-1-(2-Chloroacetyl) pyrrolidine-2-carbonitrile, 2-N-Propyl-4-methyl-6-(1-methyl benzimidazole-2-yl) benzimidazole, Isobutyramide, 4-Aminobenzonitrile, Valeronitrile and others. Its manufacturing facilities are situated at Sadasivapet Mandal, Sangareddy District, Telangana State.
Directors
- Sai Vankineni CHM
- Chandra Mouliswar Reddy Gangavaram EDR
- Balasubba Reddy Mamilla EDR
- Vedavathi Gangavaram NED
- Veera Reddy Arava NID
- Sidda Reddy Kanuparthi NID
- Sharvari Shinde NID
- Kumkum Bajaj CCO
- Prasad Battinapatla CFO
- Amireddy Reddy EDR
- Janardhana Yeddula NID (67)
- Last Annual
- March 31st, 2026
- Last Interim
- September 30th, 2026
- Incorporated
- November 27th, 1990
- Public Since
- July 25th, 1994
- No. of Employees
- 170
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 36,983,500
- Address
- 170/C, HYDERABAD, 500037
- Web
- https://oxygentapharma.com
- Phone
- +91 4023543690
- Auditors
- AM Reddy & D R Reddy
Latest News for 524636
Upcoming Events for 524636
Q3 2026 Oxygenta Pharmaceutical Ltd Earnings Release
Similar to 524636
Aayush Wellness
Bombay Stock Exchange
Accretion Nutraveda
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
FAQ
As of Today at 12:33 UTC, shares in Oxygenta Pharmaceutical are trading at IN₹50.77. This share price information is delayed by 15 minutes.
Shares in Oxygenta Pharmaceutical last closed at IN₹50.77 and the price had moved by -16.73% over the past 365 days. In terms of relative price strength the Oxygenta Pharmaceutical share price has underperformed the S&P BSE 100 Index by -15.23% over the past year.
There is no consensus recommendation for this security.
Find out moreOxygenta Pharmaceutical does not currently pay a dividend.
Oxygenta Pharmaceutical does not currently pay a dividend.
Oxygenta Pharmaceutical does not currently pay a dividend.
To buy shares in Oxygenta Pharmaceutical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹50.77, shares in Oxygenta Pharmaceutical had a market capitalisation of IN₹1.88bn.
Here are the trading details for Oxygenta Pharmaceutical:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524636
Based on an overall assessment of its quality, value and momentum Oxygenta Pharmaceutical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Oxygenta Pharmaceutical. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -14.17%.
As of the last closing price of IN₹50.77, shares in Oxygenta Pharmaceutical were trading -2.92% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Oxygenta Pharmaceutical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹50.77.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Oxygenta Pharmaceutical's management team is headed by:
- Sai Vankineni - CHM
- Chandra Mouliswar Reddy Gangavaram - EDR
- Balasubba Reddy Mamilla - EDR
- Vedavathi Gangavaram - NED
- Veera Reddy Arava - NID
- Sidda Reddy Kanuparthi - NID
- Sharvari Shinde - NID
- Kumkum Bajaj - CCO
- Prasad Battinapatla - CFO
- Amireddy Reddy - EDR
- Janardhana Yeddula - NID